Tristel Plc (LON:TSTL) had its target price boosted by analysts at FinnCap from GBX 140 ($1.73) to GBX 150 ($1.86) in a research report issued to clients and investors on Monday. The firm currently has a “corporate” rating on the stock. FinnCap’s target price suggests a potential downside of 7.41% from the company’s previous close.

Tristel Plc (LON:TSTL) opened at 159.66 on Monday. Tristel Plc has a one year low of GBX 87.11 and a one year high of GBX 169.00. The firm’s 50-day moving average price is GBX 145.58 and its 200 day moving average price is GBX 124.75. The firm’s market cap is GBX 66.66 million.

In other Tristel Plc news, insider Orr ,David acquired 12,511 shares of the business’s stock in a transaction dated Thursday, July 21st. The shares were acquired at an average price of GBX 122 ($1.51) per share, for a total transaction of £15,263.42 ($18,890.37).

About Tristel Plc

Tristel plc is a United Kingdom-based manufacturer of infection prevention and contamination control products. The Company operates through three segments: Human Healthcare, Animal Healthcare and Contamination Control. The Human Healthcare segment is engaged in the manufacture, development and sale of infection control and hygiene products, which include products that are used for infection control in hospitals.

Receive News & Ratings for Tristel Plc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Tristel Plc and related companies with's FREE daily email newsletter.